BECHINI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.863
NA - Nord America 11.531
AS - Asia 4.034
SA - Sud America 565
OC - Oceania 202
AF - Africa 118
Continente sconosciuto - Info sul continente non disponibili 2
Totale 28.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.452
RU - Federazione Russa 3.354
PL - Polonia 3.243
IT - Italia 1.941
HK - Hong Kong 1.128
SG - Singapore 1.052
IE - Irlanda 862
SE - Svezia 737
CN - Cina 588
BR - Brasile 489
DE - Germania 424
FI - Finlandia 307
IN - India 279
GB - Regno Unito 206
AU - Australia 197
JO - Giordania 179
FR - Francia 176
CH - Svizzera 167
KR - Corea 165
TR - Turchia 157
UA - Ucraina 109
ID - Indonesia 108
NL - Olanda 95
VN - Vietnam 82
CI - Costa d'Avorio 45
TH - Thailandia 45
ES - Italia 44
IR - Iran 41
PH - Filippine 33
CA - Canada 32
AR - Argentina 30
MX - Messico 26
BE - Belgio 23
CZ - Repubblica Ceca 23
BD - Bangladesh 19
TW - Taiwan 19
ZA - Sudafrica 19
GR - Grecia 18
PE - Perù 18
SA - Arabia Saudita 18
AT - Austria 16
PT - Portogallo 14
BG - Bulgaria 13
JP - Giappone 13
LT - Lituania 13
LV - Lettonia 13
HR - Croazia 12
MY - Malesia 12
IQ - Iraq 11
PK - Pakistan 11
SI - Slovenia 10
AE - Emirati Arabi Uniti 9
MA - Marocco 9
RO - Romania 9
SC - Seychelles 9
UZ - Uzbekistan 9
EC - Ecuador 8
KZ - Kazakistan 8
KE - Kenya 7
VE - Venezuela 7
AZ - Azerbaigian 6
BH - Bahrain 6
CY - Cipro 6
EG - Egitto 6
HU - Ungheria 6
AL - Albania 5
CO - Colombia 5
IL - Israele 5
NO - Norvegia 5
NP - Nepal 5
AM - Armenia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
CL - Cile 3
CR - Costa Rica 3
ET - Etiopia 3
FJ - Figi 3
GA - Gabon 3
JM - Giamaica 3
NG - Nigeria 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BB - Barbados 2
CM - Camerun 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
IS - Islanda 2
KG - Kirghizistan 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
SM - San Marino 2
Totale 28.296
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.712
Warsaw 3.224
Hong Kong 933
Fairfield 862
Dublin 855
Chandler 724
Singapore 660
Ashburn 489
Cambridge 371
Seattle 359
Woodbridge 350
Florence 322
Houston 302
Wilmington 281
Princeton 239
Beijing 222
Lawrence 210
Altamura 207
Mumbai 193
Moscow 181
Jacksonville 180
Boston 178
Buffalo 174
Ann Arbor 153
Bern 151
Munich 146
Boardman 143
Melbourne 133
Rome 117
New York 113
Medford 95
Shanghai 95
Jakarta 93
Turku 81
Los Angeles 78
Milan 78
Paris 77
San Diego 75
Izmir 71
Kent 69
Helsinki 66
Dong Ket 56
Hefei 54
Abidjan 45
Sydney 45
London 43
Bremen 41
Norwalk 41
São Paulo 41
Dearborn 36
Naples 34
Bangkok 32
Falkenstein 29
Hillsboro 28
Falls Church 23
Phoenix 23
Bengaluru 22
Frankfurt am Main 22
Genoa 22
Andover 21
Seoul 21
Yubileyny 21
Barcelona 20
Seodaemun-gu 20
Rio de Janeiro 19
Amsterdam 18
Bari 17
Lima 17
Seo-gu 17
Toronto 17
Brussels 16
Padova 16
Palermo 16
Bologna 15
Gangnam-gu 15
Pune 15
Ancona 14
Catania 14
Pisa 14
Plymouth 14
Roelofarendsveen 14
West Jordan 14
Hamburg 13
Redwood City 13
Riga 13
Riyadh 13
The Dalles 13
Cagliari 12
Goyang-si 12
Lappeenranta 12
Manchester 12
Philadelphia 12
Salvador 12
Baltimore 11
Guangzhou 11
Ankara 10
Auburn Hills 10
Brno 10
Rimini 10
Turin 10
Totale 18.293
Salva come PNG Salva come JPEG
Nome #
Measuring health literacy in Italy: A validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in Florence and its surroundings 1.124
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 487
HPV vaccination for boys? A systematic review of economic studies 356
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 319
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 294
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 267
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 259
Human papilloma virus vaccination: impact and recommendations across the world. 259
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 257
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 253
Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language 252
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 248
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 239
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 238
The epidemiology of mumps in Italy 235
The epidemiology of Varicella Zoster Virus infection in Italy. 232
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 218
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 215
Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy 214
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 212
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 199
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 198
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 197
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 193
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 188
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: Results of a semi-quantitative survey 181
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 176
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 171
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 168
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries 167
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 166
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 162
Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence 159
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 159
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 158
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 157
Progress in Italy in control and elimination of measles and congenital rubella. 154
Recommended vaccinations for asplenic and hyposplenic adult patients 152
INCREASING RESISTANCE IN COMMENSAL ESCHERICHIA COLI, BOLIVIA AND PERU 147
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 146
Progress in Italy in control and elimination of measles and congenital rubella. 144
Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project 141
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 137
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 137
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 137
Health literacy and vaccination: A systematic review 134
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 133
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 131
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 130
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 128
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 124
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 124
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. 123
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 122
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 122
An overview on the implementation of HPV vaccination in Europe. 121
Electronic Package Leaflets for Vaccines: What Are People's Perceptions in Italy? 120
Epidemiologia storica della rosolia in Toscana e nuovo flusso di notifica obbligatoria 120
Gli operatori sanitari degli ospedali fiorentini: protetti o non protetti verso morbillo, parotite, rosolia e varicella? 120
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 118
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 118
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 118
Evaluating the costs and benefits of pneumococcal vaccination in adults 118
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 117
Focusing on the implementation of 21st century vaccines for adults 117
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 117
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 116
Valutazione dell’immunità umorale e cellulo-mediata verso Bordetella pertussis in Toscana 116
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 115
Le abitudini sessuali e i fattori di rischio per l'infezione da HPV degli studenti di Infermieristica dell'Università di Firenze: uno studio pilota 115
La sorveglianza di laboratorio dei casi di sospetto morbillo in Toscana dal 2004 al 2012. 114
20 anni di vaccinazione anti-epatite B in Italia: una valutazione economica. 114
Application of socio-economic-health deprivation index, analysis of mortality and influenza vaccination coverage in the elderly population of Tuscany 114
Epatite B e C: pratiche di counselling e referral in soggetti migranti (progetto HEPSCREEN) 114
Key points for the decision maker 113
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence 112
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 112
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 112
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 110
Awareness of hepatitis B and C screening and patient management guidelines among health professionals in six European countries 110
Assessment of the clinical and economic impact of different immunization protocols of measles, mumps, rubella and varicella in internationally adopted children 110
Discrepancies between vaccine documentation and serologic status for diphtheria, tetanus, and hepatitis b in internationally adopted children 110
High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy 110
The role of health literacy in covid-19 preventive behaviors and infection risk perception: Evidence from a population-based sample of essential frontline workers during the lockdown in the province of prato (tuscany, italy) 110
The burden of disease of Herpes Zoster in Tuscany 109
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 109
Le abitudini sessuali e i fattori di rischio per l’infezione da HPV degli studenti toscani. 109
Factors influencing sars-cov-2 vaccine acceptance and hesitancy in a population-based sample in Italy 109
The expected impact of new vaccines and vaccination policies. 108
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 108
Perspectives of public health: present and foreseen impact of vaccination on the epidemiology of hepatitis B 107
Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014 107
Analisi economica della vaccinazione anti-varicella nei bambini e negli adolescenti italiani: il peso delle ospedalizzazioni senza complicazioni. 106
Donne in gravidanza e vaccinazioni: impatto di un intervento educativo nel territorio fiorentino 106
Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. 106
Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. 106
A cost-benefit analysis of different varicella vaccination strategies involving italian children and adolescents. 105
Measurement and reporting of burden of disease for hepatitis a: results of the EUROHEP.NET feasibility survey 104
Why the anti-meningococcal b vaccination during adolescence should be implemented in italy: An overview of available evidence 104
Un caso di studio su una sospetta associazione tra vaccinazione anti-varicella e reazione avversa a vaccino. 104
Totale 16.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.932 158 195 80 201 110 234 96 148 176 308 77 149
2021/20221.452 55 180 82 54 38 38 47 128 40 59 270 461
2022/20234.050 344 616 219 259 250 706 543 235 529 28 134 187
2023/20242.545 88 201 296 177 227 292 195 340 109 228 222 170
2024/202512.170 467 1.277 796 1.816 3.319 1.625 243 648 534 367 491 587
2025/2026635 635 0 0 0 0 0 0 0 0 0 0 0
Totale 28.581